ACTA1 and neoplasm: Consistent with subsequent clinical failure of strategies targeting CAFs, genetic or pharmacological depletion of myofibroblasts (α-SMA expressing fibroblasts) was found to accelerate tumour progression due to the emergence of more undifferentiated tumours.